Altus Wealth Group
ABBV icon

Altus Wealth Group’s AbbVie ABBV Stock Holding History

Altus Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.03M Sell
3,936
-115
-3% -$29.5K 0.39% 39
2026
Q2 		$1.02M Buy
4,051
+173
+4% +$37.2K 0.37% 48
2026
Q1 		$843K Buy
3,878
+115
+3% +$25.5K 0.35% 60
2025
Q4 		$860K Buy
3,763
+62
+2% +$14.1K 0.34% 58
2025
Q3 		$857K Sell
3,701
-133
-3% -$27.1K 0.35% 56
2025
Q2 		$712K Buy
3,834
+510
+15% +$94.8K 0.31% 61
2025
Q1 		$696K Sell
3,324
-440
-12% -$85.5K 0.33% 62
2024
Q4 		$669K Buy
3,764
+148
+4% +$27.2K 0.3% 74
2024
Q3 		$714K Buy
3,616
+186
+5% +$34.7K 0.31% 72
2024
Q2 		$588K Hold
3,430
– – 0.29% 74
2024
Q1 		$625K Buy
3,430
+76
+2% +$13.1K 0.31% 74
2023
Q4 		$520K Sell
3,354
-226
-6% -$32.9K 0.29% 80
2023
Q3 		$534K Sell
3,580
-25
-0.7% -$3.67K 0.34% 72
2023
Q2 		$486K Buy
3,605
+310
+9% +$45.5K 0.3% 80
2023
Q1 		$525K Hold
3,295
– – 0.35% 71
2022
Q4 		$533K Buy
3,295
+509
+18% +$78K 0.4% 65
2022
Q3 		$301K Hold
2,786
– – 0.3% 81
2022
Q2 		$301K Sell
2,786
-11
-0.4% -$1.68K 0.3% 81
2022
Q1 		$453K Sell
2,797
-25
-0.9% -$3.63K 0.37% 62
2021
Q4 		$382K Buy
2,822
+36
+1% +$4.25K 0.32% 73
2021
Q3 		$301K Buy
2,786
+382
+16% +$43.6K 0.3% 81
2021
Q2 		$271K Hold
2,404
– – 0.26% 85
2021
Q1 		$274K Sell
2,404
-660
-22% -$70.6K 0.27% 83
2020
Q4 		$329K Buy
+3,064
New +$294K 0.31% 63

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Altus Wealth Group's ABBV Position: Q3 2026 in Review

Altus Wealth Group reduced its AbbVie (ABBV) stake by 2.8% in Q3 2026, selling an estimated $29.5K and leaving 3,936 shares worth $1.03M. The position accounts for 0.39% of the portfolio, ranked #39.

Altus Wealth Group first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Altus Wealth Group held 3,936 shares of AbbVie worth $1.03M as of Q3 2026.
  • Altus Wealth Group sold 115 AbbVie shares in Q3 2026, an estimated $29.5K.
  • AbbVie made up 0.39% of Altus Wealth Group's portfolio in Q3 2026, its #39 holding.
  • Altus Wealth Group first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
  • 2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Altus Wealth Group's 13F filing for Q3 2026, filed 20 Oct 2026.